CN1211096C - Chinese medicine for treating pelvic infection and its production process - Google Patents
Chinese medicine for treating pelvic infection and its production process Download PDFInfo
- Publication number
- CN1211096C CN1211096C CN 00133689 CN00133689A CN1211096C CN 1211096 C CN1211096 C CN 1211096C CN 00133689 CN00133689 CN 00133689 CN 00133689 A CN00133689 A CN 00133689A CN 1211096 C CN1211096 C CN 1211096C
- Authority
- CN
- China
- Prior art keywords
- gram
- medicine
- treatment
- grams
- chinese patent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a Chinese patent medicine made of Chinese herbal medicines for curing various pelvic inflammation, and a preparation method. The present invention provides a curative medicine having the advantages of good curative effect, short course of treatment, no side effect, convenient administration and low price and particularly suitable for treatment of extensive rural women according to the pathogenic mechanisms and pathological changes of the pelvic inflammation, performance, functions and mechanisms of Chinese herbal medicines, and characteristics of modern pharmaceutical research. The Chinese patent medicine is prepared from 40 g of Chinese angelica, 40g of nutgrass galingale rhizome, 100g of dandelion, 30g of radix paeoniae alba, 20g of perilla stem, 30 g of hemlock parsley, 100 g of honeysuckle flower, 50g of wolfberry bark, 20g of glycyrrhiza and 150 of purslane herb. The present invention has the functions of clearing away heat and toxic material. Relieving inflammation, alleviating pain, promoting blood circulation, dissipating blood stasis, and softening and resolving hard masses.
Description
The present invention is a Chinese patent medicine, treats various pelvic inflammatory disease.With the Chinese herbal medicine is raw material and preparation method.
Pelvic inflammatory disease is the common frdquently encountered disease of department of obstetrics and gynecology, is the highest disease of harm WomanHealth sickness rate in the obstetrical and gynecological disease, and especially rural women's sickness rate is higher, influences women productivity greatly.
Sub-antibiotics antiinflammatory and symptomatic treatment are limited in the treatment of pelvic inflammatory disease since the eighties.Because the long-term extensive use of antibiotics strengthens pathogenic bacterium Drug resistance and patience.The etiology and pathogenesis that adds pelvic inflammatory disease again is complicated, and course of disease delay forms the chronic inflammatory enclosed mass sometimes, and antibiotics antiinflammatory effect is often not obvious.
The present invention is according to the pathogeny and the pathological change of pelvic inflammatory disease, and according to property of Chinese materia medica effect and mechanism and modern pharmacy research characteristics, purpose is to provide a kind of good effect, short treating period has no side effect, taking convenience, low-cost, especially be fit to the medicine that numerous rural women treat needs.
Clinical Practice proving effect of the present invention is remarkable, through Jilin health bureau ratify in 1981 the beginning institute in Drug Manufacturing Room's production self-marketing, one nine nine zero years obtain Jilin medical and health scientific and technological progress third prize, exchange in the 999 year medical science seminar held of U.S. Los Angeles and obtain the first prize.
Prescription: Radix Angelicae Sinensis 40 grams, Rhizoma Cyperi 40 grams, Herba Taraxaci 100 grams, the Radix Paeoniae Alba 30 grams, Caulis Perillae 20 grams, Rhizoma Chuanxiong 30 grams, Flos Lonicerae 100 grams, Cortex Lycii 50 grams, Radix Glycyrrhizae 20 grams, Herba Portulacae 150 grams.
Pharmacological action: heat-clearing and toxic substances removing, anti-inflammatory analgetic, blood circulation promoting and blood stasis dispelling, hard masses softening and resolving.
1, expansion pelvic blood vessels increases pelvic cavity internal reproductive organ blood flow, the activation histiocyte.
2, expansion pelvic cavity blood capillary increases uterus and each ligament microcirculation of ovary and anti-damaging action.
3, microcirculation improvement increases the hemoperfusion amount, improves the pelvic muscle function, enhances metabolism.
4, pelvic inflammatory disease is invaded human body by pathogen, causes the blood clotting stagnation of QI, and officer's title in Tang dynasty's blood stasis is obstructed, the true disease of stagnation of QI and blood may bring about pain, thus blood circulation promoting and blood stasis dispelling, the hard eliminating stagnation that disappears, QI and blood regulating, the heat-clearing and toxic substances removing depressed liver-energy dispersing and QI regulating, anti-inflammatory analgesic promotes adrenal cortex function, improves immune level.
5, reduce the permeability of blood capillary, suppress the synthetic and release of PGE, anti-platelet aggregation increases regional blood flow, and minimizing is oozed out, and increases the supply of blood oxygen, and inflammation absorbs.
6, the Chinese patent medicine for the treatment of pelvic inflammatory disease synthesizes by inflammation-inhibiting position PGE, and the protection lysosome membrane prevents to destroy, the release of Profilin hydrolytic enzyme, thus inhibition causes inflammation, causes the release of pain medium.
7, be applicable to: the various inflammation of gynecological, urgent chronic pelvic inflammatory disease, pelvic cavity sheath inflammation.
Therapeutic effect proves: 1218 routine pelvic inflammatory disease patients are shown with the Chinese patent drugs for treatment structure and the matched group comparative result of treatment pelvic inflammatory disease: it is 97.4% that the Chinese patent drugs for treatment group of treatment pelvic inflammatory disease is cured obvious effective rate, and matched group is that there were significant differences between 86.75%, two group.Chronic pelvic inflammatory enclosed mass, the Chinese patent drugs for treatment group of treatment pelvic inflammatory disease are cured obvious effective rate and are reached 100%, and simple antibiotherapy has only 57%.
Production method:
1, press the optimum weight proportioning blanking of medicine of the present invention:
Flos Lonicerae 5kg Radix Paeoniae Alba 1.5kg Rhizoma Chuanxiong 1.5kg Herba Taraxaci 5kg Radix Angelicae Sinensis 2kg
Rhizoma Cyperi 2kg Caulis Perillae 1.5kg Radix Glycyrrhizae 1.5kg Cortex Lycii 2.5kg Herba Portulacae 30kg
Mel 78.75kg
2, get Herba Portulacae earlier and singly fry in shallow oil 24 hours one-tenth juice, filter, abandon medicinal residues, fry in shallow oil into extractum again, add Flos Lonicerae and mix well oven dry, be crushed to 120 order fine powders;
3, all the other medicine oven dry are crushed to 120 order fine powders, ultraviolet radiation disinfection;
4, refined honey is 45 minutes 2 times;
5, with above-mentioned whole powder mixings, stir and in honey, beat ball, packing.
6, every ball 6 grams of specification, every bag 10 ball.
Instructions of taking: obey 1 ball, every day twice, eliminating cold for resuscitation water is obeyed down on an empty stomach sooner or later at every turn, and serious symptom can add to 3 times and obey or each 2 balls.No contraindication and side effect, 10 days is a course of treatment.
Claims (2)
1, a kind of Chinese patent medicine for the treatment of pelvic inflammatory disease is characterized in that this medicine made by following raw material:
The Radix Angelicae Sinensis 40 gram Rhizoma Cyperis 40 gram Herba Taraxacis 100 gram Radix Paeoniae Albas 30 grams
Caulis Perillae 20 gram Rhizoma Chuanxiongs 30 gram Flos Loniceraes 100 gram Cortex Lycii 50 grams
Radix Glycyrrhizae 20 KEMA bitterroots 150 grams
2, according to the Chinese patent medicine preparation method of the described treatment pelvic inflammatory disease of claim 1, it is characterized in that preparing by the following method:
Get Herba Portulacae earlier and singly fry in shallow oil 24 hours one-tenth juice, filter, abandon medicinal residues, fry in shallow oil into extractum again, add Flos Lonicerae and mix well oven dry, be crushed to 120 order fine powders; All the other medicine oven dry are crushed to 120 order fine powders, ultraviolet radiation disinfection; Refined honey 45 minutes 2 times; With above-mentioned whole powder mixings, stir and in honey, beat ball.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00133689 CN1211096C (en) | 2000-12-04 | 2000-12-04 | Chinese medicine for treating pelvic infection and its production process |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00133689 CN1211096C (en) | 2000-12-04 | 2000-12-04 | Chinese medicine for treating pelvic infection and its production process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1387865A CN1387865A (en) | 2003-01-01 |
| CN1211096C true CN1211096C (en) | 2005-07-20 |
Family
ID=4595904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 00133689 Expired - Fee Related CN1211096C (en) | 2000-12-04 | 2000-12-04 | Chinese medicine for treating pelvic infection and its production process |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1211096C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100376286C (en) * | 2006-04-10 | 2008-03-26 | 庞来祥 | Medicinal composition for treating chronic pelvic inflammatory disease, prepn. method and quality control method therefor |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101019981B (en) * | 2007-03-15 | 2011-08-17 | 北京同御康泰科技有限公司 | Chinese medicine preparation and its preparing process |
| CN104274647A (en) * | 2014-10-13 | 2015-01-14 | 李俊平 | Medicine for treating pelvic inflammation and preparation method thereof |
| CN105616749A (en) * | 2014-10-31 | 2016-06-01 | 镇江泰飞尔医药有限公司 | Traditional Chinese medicine preparation for treating gynecologic inflammation and preparation method thereof |
-
2000
- 2000-12-04 CN CN 00133689 patent/CN1211096C/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100376286C (en) * | 2006-04-10 | 2008-03-26 | 庞来祥 | Medicinal composition for treating chronic pelvic inflammatory disease, prepn. method and quality control method therefor |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1387865A (en) | 2003-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1323673C (en) | Medicinal formulation for treating upper respiratory track infection and its design method | |
| CN102178895B (en) | Chinese medicine composition for treating orthopedic disorders and preparation method thereof | |
| CN102366508A (en) | Traditional Chinese medicine preparation for treating obstructive infertility of fallopian tube | |
| CN103341079B (en) | Chinese medicine composition for treating acne | |
| CN101181419B (en) | Chinese medicine composition for curing simple periodontitis | |
| CN100396328C (en) | Combined medicine for preventing and treating rheumatism, rheumatoid, protrusion of intervertebral disc and hyperosteogeny | |
| CN103356877A (en) | Traditional Chinese medicine composition for treating orthopedic diseases | |
| CN100536897C (en) | A Chinese traditional medicinal composition for treatment of psoriasis | |
| CN1739611A (en) | Stasis relieving oral liquid for treating rhinitis and its prepn | |
| CN1211096C (en) | Chinese medicine for treating pelvic infection and its production process | |
| CN1919289A (en) | Decoction medicine for treating urethritis with vaginal pruritus and its preparing process | |
| CN102580142B (en) | Chinese medicinal liniment for postoperative healing of orthopaedic surgery and preparation method | |
| CN1352957A (en) | Medicine for treating cervical vertebra disease | |
| CN1915385A (en) | Medication of medical broth for treating urethritis in type of hematuria, and preparation method | |
| CN100335116C (en) | Medicament for treating leprous psora | |
| CN101095810B (en) | Decoction medicine for treating seborrhoeic dermatitis and method for preparing the same | |
| CN1129439C (en) | Hyperosteogeny-treating capsule | |
| CN112717096A (en) | Chinese herbal medicine foot bath powder capable of reducing uric acid and dissipating wind and tonifying kidney | |
| CN1919325A (en) | Decoction medicine for treating urethritis of urine turbidity type and its preparing process | |
| CN110638955A (en) | Chinese medicinal composition for treating arthralgia | |
| CN103372187A (en) | Medicine for treating urticaria | |
| CN1919290A (en) | Decoction medicine for treating urethritis of lumbago type and its preparing process | |
| CN1919288A (en) | Decoction medicine for treating acute swollen urethritis and its preparing process | |
| CN101284119A (en) | Compound antitoxic pill | |
| CN101810748A (en) | Formula of orally-taken Chinese medicament for treating chronic prostatitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20160706 Address after: 133000, Hongyun street, Xinxing Industrial Zone, Yanbian Korean Autonomous Prefecture, Jilin, Yanbian Province, 955 Patentee after: Wang Ying Address before: 132400 Huadian Hospital of Jilin Province Patentee before: Yang Shurong |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050720 Termination date: 20171204 |